Literature DB >> 22688254

Unilateral uterine ischemia/reperfusion-induced bilateral fetal loss and fetal growth restriction in a murine model require intact complement component 5.

Xiao-Wu Qu1, Tamas Jilling, Mark G Neerhof, Kehuan Luo, Emmet Hirsch, Larry G Thaete.   

Abstract

The role of complement in ischemia/reperfusion-induced fetal growth restriction and fetal loss is unknown. C5-deficient or wild type timed-pregnant mice were subjected to unilateral uterine ischemia/reperfusion on gestation day 13, either by (1) partial flow restriction by right ovarian artery clamping for 30 min, or (2) total flow restriction by clamping both ovarian and uterine arteries for 5 min. Ischemia/reperfusion-challenged pregnancy outcomes were compared to sham-operated controls 5 days later. Ischemia/reperfusion-treated wild type mice exhibited significantly increased bilateral fetal loss, which was greater in total flow restriction than in partial flow restriction, and decreased fetal weights, which were the same in total flow restriction and partial flow restriction for the surviving fetuses. Placental weights were unchanged by treatments. Ischemia/reperfusion increased uterine, but not placental, myeloperoxidase activity, which correlated with fetal loss. In contrast, C5-deficient mice were protected from both fetal growth restriction and fetal loss, and exhibited no increase in myeloperoxidase activity. These results demonstrate that unilateral uterine ischemia/reperfusion results in bilateral fetal loss and fetal growth restriction, mediated by a systemic mechanism. In the current model, this pathological process is completely dependent on intact complement component 5.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22688254      PMCID: PMC3432748          DOI: 10.1016/j.jri.2012.04.005

Source DB:  PubMed          Journal:  J Reprod Immunol        ISSN: 0165-0378            Impact factor:   4.054


  38 in total

Review 1.  Aspects of human fetoplacental vasculogenesis and angiogenesis. III. Changes in complicated pregnancies.

Authors:  T M Mayhew; D S Charnock-Jones; P Kaufmann
Journal:  Placenta       Date:  2004 Feb-Mar       Impact factor: 3.481

2.  Excessive complement activation is associated with placental injury in patients with antiphospholipid antibodies.

Authors:  Jaime M Shamonki; Jane E Salmon; Elizabeth Hyjek; Rebecca N Baergen
Journal:  Am J Obstet Gynecol       Date:  2007-02       Impact factor: 8.661

3.  Role of leukocytes in uterine hypoperfusion and fetal growth retardation induced by ischemia-reperfusion.

Authors:  K Miyakoshi; H Ishimoto; O Nishimura; S Tanigaki; M Tanaka; T Miyazaki; M Natori; Y Yoshimura
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-03       Impact factor: 4.733

4.  The C5b-9 membrane attack complex of complement activation localizes to villous trophoblast injury in vivo and modulates human trophoblast function in vitro.

Authors:  R Rampersad; A Barton; Y Sadovsky; D M Nelson
Journal:  Placenta       Date:  2008-09-09       Impact factor: 3.481

5.  LPS-induced murine abortions require C5 but not C3, and are prevented by upregulating expression of the CD200 tolerance signaling molecule.

Authors:  Gary Yu; Yang Sun; Katharina Foerster; Justin Manuel; Hector Molina; Gary A Levy; Reginald M Gorczynski; David A Clark
Journal:  Am J Reprod Immunol       Date:  2008-08       Impact factor: 3.886

6.  Activation of complement mediates antiphospholipid antibody-induced pregnancy loss.

Authors:  J E Salmon; G Girardi; V M Holers
Journal:  Lupus       Date:  2003       Impact factor: 2.911

Review 7.  Myeloperoxidase: a target for new drug development?

Authors:  E Malle; P G Furtmüller; W Sattler; C Obinger
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

8.  Infusion of exogenous platelet-activating factor produces intrauterine growth restriction in the rat.

Authors:  Larry G Thaete; Mark G Neerhof; Tamas Jilling; Michael S Caplan
Journal:  J Soc Gynecol Investig       Date:  2003-04

9.  C5aR-mediated myocardial ischemia/reperfusion injury.

Authors:  Haimou Zhang; Gangjian Qin; Gang Liang; Jinan Li; Robert A Barrington; Dong-Xu Liu
Journal:  Biochem Biophys Res Commun       Date:  2007-04-02       Impact factor: 3.575

10.  Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction.

Authors:  Guillermina Girardi; Dmitry Yarilin; Joshua M Thurman; V Michael Holers; Jane E Salmon
Journal:  J Exp Med       Date:  2006-08-21       Impact factor: 14.307

View more
  2 in total

Review 1.  The complement system and adverse pregnancy outcomes.

Authors:  Jean F Regal; Jeffrey S Gilbert; Richard M Burwick
Journal:  Mol Immunol       Date:  2015-03-21       Impact factor: 4.407

2.  Mild intrauterine hypoperfusion reproduces neurodevelopmental disorders observed in prematurity.

Authors:  Makiko Ohshima; Jacques-Olivier Coq; Kentaro Otani; Yorito Hattori; Yuko Ogawa; Yoshiaki Sato; Mariko Harada-Shiba; Masafumi Ihara; Masahiro Tsuji
Journal:  Sci Rep       Date:  2016-12-20       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.